Sai Life Sciences Limited (BOM:544306)
India · Delayed Price · Currency is INR 1,264.15
+27.60 (2.23%)
At close: Jul 10, 2026
Sai Life Sciences Revenue
In the fiscal year ending March 31, 2026, Sai Life Sciences had annual revenue of 21.92B INR with 29.38% growth. Sai Life Sciences had revenue of 6.02B in the quarter ending March 31, 2026, with 3.91% growth.
Revenue
21.92B
Revenue Growth
+29.38%
P/S Ratio
12.24
Revenue / Employee
6.45M
Employees
3,401
Market Cap
268.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 21.92B | 4.98B | 29.38% |
| Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mangalore Refinery and Petrochemicals | 886.67B |
| TVS Holdings | 502.36B |
| NBCC (India) | 131.96B |
| Cemindia Projects | 100.61B |
| Sterlite Technologies | 47.45B |
| Procter & Gamble Hygiene and Health Care | 42.90B |
| Gillette India | 31.00B |
| ITI Limited | 21.84B |
Sai Life Sciences News
- 2 months ago - Sai Life Sciences Transcript: Q4 25/26 - Transcripts
- 2 months ago - Sai Life Sciences Quarterly report: Q4 2026 - Filings
- 2 months ago - Sai Life Sciences Slides: Q4 2026 - Filings
- 5 months ago - Sai Life Sciences Transcript: Q3 25/26 - Transcripts
- 5 months ago - Sai Life Sciences Quarterly report: Q3 2026 - Filings
- 5 months ago - Sai Life Sciences Slides: Q3 2026 - Filings
- 8 months ago - Sai Life Sciences Transcript: Q2 25/26 - Transcripts
- 8 months ago - Sai Life Sciences Quarterly report: Q2 2026 - Filings